Results of phase I plus expansion cohorts of cabozantinib (Cabo) plus nivolumab (Nivo) and CaboNivo plus ipilimumab (Ipi) in patients (pts) with with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignancies.
暂无分享,去创建一个
S. Steinberg | H. Parnes | M. Bagheri | S. Pal | A. Apolo | R. Nadal | W. Dahut | M. Stein | E. Mena | D. Bottaro | R. Costello | A. Mortazavi | L. Lindenberg | L. Cordes | N. Davarpanah | Y. Ning | Ryan Thompson | Tina Moore | Tiffany Lancaster | M. Velez | R. Thompson